Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 46.49%
March 31, 2026 46.61%
December 31, 2025 44.33%
September 30, 2025 45.06%
June 30, 2025 48.54%
March 31, 2025 44.68%
December 31, 2024 44.66%
September 30, 2024 48.80%
June 30, 2024 48.60%
March 31, 2024 47.09%
December 31, 2023 45.78%
September 30, 2023 46.02%
June 30, 2023 41.62%
March 31, 2023 42.02%
December 31, 2022 40.93%
September 30, 2022 44.99%
Date Value
June 30, 2022 49.11%
March 31, 2022 47.96%
December 31, 2021 48.46%
September 30, 2021 47.58%
June 30, 2021 45.38%
March 31, 2021 45.61%
December 31, 2020 43.36%
September 30, 2020 47.31%
June 30, 2020 28.58%
March 31, 2020 29.77%
December 31, 2019 -53.92%
September 30, 2019 -30.55%
June 30, 2019 -19.30%
March 31, 2019 -50.00%
December 31, 2018 -141.0%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. 50.03%
Trulieve Cannabis Corp. 50.40%
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --

Gross Profit Margin (Quarterly) Related Metrics